(Q28185617)

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Mirtazapine compared with paroxetine in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

The use of pindolol with fluoxetine in the treatment of major depression: final results from a double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Effects of the co-administration of mirtazapine and paroxetine on serotonergic neurotransmission in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

ECT in bipolar and unipolar depression: differences in speed of response

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Sequential catecholamine and serotonin depletion in mirtazapine-treated depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Early onset of antidepressant action of venlafaxine: pattern analysis in intent-to-treat patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

The sleep therapies of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Effects of long-term treatment with the alpha 2-adrenoceptor antagonist mirtazapine on 5-HT neurotransmission

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Increased tonic activation of rat forebrain 5-HT(1A) receptors by lithium addition to antidepressant treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Comparison between zimeldine and amitriptyline of efficacy and adverse symptoms--a combined analysis of four British clinical trials in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Nonparametric estimation and testing in a cure model.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Clozapine inhibits serotoninergic transmission by an action at alpha 1-adrenoceptors not at 5-HT1A receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the alpha 1-adrenergic, dopamine and serotonin systems.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Rapid onset of action of venlafaxine.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Selecting methodologies for the evaluation of differences in time to response between antidepressants

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Lack of beta adrenoceptor desensitization in brain following the dual noradrenaline and serotonin reuptake inhibitor venlafaxine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Mirtazapine: pharmacology in relation to adverse effects

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Augmentation of fluoxetine's antidepressant action by pindolol: analysis of clinical, pharmacokinetic, and methodologic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Identification of true drug response to antidepressants. Use of pattern analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Pindolol augmentation of selective serotonin reuptake inhibitors: PET evidence that the dose used in clinical trials is too low.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Time course of improvement under antidepressant treatment: a survival-analytical approach

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Effect of the selective noradrenergic reuptake inhibitor reboxetine on the firing activity of noradrenaline and serotonin neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Modulation of noradrenergic neuronal firing by selective serotonin reuptake blockers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Morphological study of noradrenaline innervation in the caudal raphe nuclei with special reference to fine structure

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Multiple substrates for serotonergic modulation of rat locus coeruleus neurons and relationships with kainate receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Effect of venlafaxine hydrochloride in different preparations of isolated guinea-pig and rat organ tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

How Long Should Pindolol Be Associated With Paroxetine to Improve the Antidepressant Response?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

Factors affecting fluvoxamine antidepressant activity: influence of pindolol and 5-HTTLPR in delusional and nondelusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2802%2900173-6

7 January 2021

10.1016/S0924-977X(02)00173-6

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

12650947

1 reference

Consolidated OpenCitations Corpus – April 2017